Cargando…

Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France

Introduction Data from clinical trials indicate that direct oral anticoagulants (DOACs) are noninferior and safer than conventional therapy (low-molecular-weight heparin followed by a vitamin K antagonist [VKA]) for treating venous thromboembolism (VTE), which includes deep vein thrombosis and pulm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertoletti, Laurent, Gusto, Gaelle, Khachatryan, Artak, Quignot, Nadia, Chaves, Jose, Moniot, Audrey, Mokgokong, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393089/ https://www.ncbi.nlm.nih.gov/pubmed/34983073 http://dx.doi.org/10.1055/a-1731-3922

Ejemplares similares

Low Molecular Weight Heparin Treatment Patterns and Outcomes in Cancer Patients with Acute Venous Thromboembolism: A Nationwide Cohort Study in France
por: Bertoletti, Laurent, et al.
Publicado: (2023)

Comparative Analysis of All-Cause Health Care Resource Utilization and Costs Among Venous Thrombosis Patients Without Cancer Prescribed Apixaban or VKAs in France
por: Mokgokong, Ruth, et al.
Publicado: (2022)

Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS)
por: Touzeau, Cyrille, et al.
Publicado: (2021)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Editorial: Venous thromboembolism and pregnancy
por: Tardy, Bernard, et al.
Publicado: (2022)

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis
por: Mai, Vicky, et al.
Publicado: (2019)

Recurrent thromboembolism, bleeding, and mortality in Asian patients with venous thromboembolism receiving different oral anticoagulants: A nationwide analysis
por: Lee, Mei-Chuan, et al.
Publicado: (2022)

Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
por: Mahé, Isabelle, et al.
Publicado: (2015)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Direct Oral Anticoagulants and Travel-related Venous Thromboembolism
por: Chamnanchanunt, Supat, et al.
Publicado: (2018)

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
por: Nakamura, Mashio, et al.
Publicado: (2017)

Direct oral anticoagulants for unusual‐site venous thromboembolism
por: Riva, Nicoletta, et al.
Publicado: (2021)

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
por: Masini, Marta, et al.
Publicado: (2023)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy
por: Finks, Shannon W., et al.
Publicado: (2016)

Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
por: Yhim, Ho-Young, et al.
Publicado: (2014)

Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer
por: Planquette, Benjamin, et al.
Publicado: (2019)

New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)

New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016)

Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)

Venous Thromboembolism While on Anticoagulation With Apixaban
por: Mazahreh, Farah, et al.
Publicado: (2021)

Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants
por: Geldhof, Vincent, et al.
Publicado: (2014)

New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities
por: Dobesh, Paul P., et al.
Publicado: (2014)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
por: Song, Andrew B, et al.
Publicado: (2019)

Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants
por: Ay, C, et al.
Publicado: (2019)

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017)

The Use of Direct Oral Anticoagulants in the Management of Venous Thromboembolism in Patients With Obesity
por: Younis, Moustafa, et al.
Publicado: (2020)

The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer
por: Park, Jeong-Yeol
Publicado: (2019)

Arguments for Using Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2021)

Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis
por: Tun, Han Naung, et al.
Publicado: (2022)

Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
por: Toth, Peter P
Publicado: (2016)

Venous thromboembolism and COVID-19
por: Bertoletti, L., et al.
Publicado: (2020)

Efficacy of Direct Oral Anticoagulant into the Care of Venous Thromboembolism Related to Kumamoto Earthquake
por: Matsukawa, Mai, et al.
Publicado: (2018)

Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism
por: Zeng, Jie, et al.
Publicado: (2019)

Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants
por: Kim, Sang-A, et al.
Publicado: (2019)

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020)

New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism
por: Wumaier, Kaidireyahan, et al.
Publicado: (2022)

Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020
por: Iyer, Geetha S., et al.
Publicado: (2023)

Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases
por: Heestermans, Marco, et al.
Publicado: (2022)

New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
por: McRae, Simon J, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_2bv24oujbl84m3cgrp945cna9h